Search Within

Azeez Farooki

Formats
  1. Journal Article (40)
  2. Meeting Abstract (24)
  3. Review (5)
  4. Book Section (3)
  5. Guidelines (3)
  6. Conference Paper (1)
Groups
  1. Department of Medicine (76)
  2. Division of Subspecialty Medicine (76)
  3. Endocrinology (76)
  4. Survivorship Research (76)
  5. Solid Tumor Oncology Division (27)
  6. Breast Medicine Service (15)

More Groups

People
  1. Monica Fornier (14)
  2. Cherry Estilo (7)
  3. Michael Morris (7)
  4. Joseph Huryn (6)
  5. Aaron Mitchell (5)
  6. Monica Girotra (5)

More People

Years
  1. 2024 (4)
  2. 2023 (5)
  3. 2022 (7)
  4. 2021 (5)
  5. 2020 (7)
  6. 2019 (7)

More Years

Publications
  1. Journal of Clinical Oncology (14)
  2. Annals of Oncology (5)
  3. Endocrine Practice (3)
  4. Contemporary Endocrinology (2)
  5. Biology of Blood and Marrow Transplantation (2)
  6. Clinical Lymphoma, Myeloma and Leukemia (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. Oxford University Press (9)
  3. Elsevier Inc. (8)
  4. Springer (6)
  5. Wiley Blackwell (5)
  6. American Association of Clinical Endocrinologists (3)

More Publishers

Results (76)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Costs to Medicare of nonrecommended bone-modifying agent use for castration-sensitive prostate cancer
    Journal Article

    Mitchell, A. P.; Nemirovsky, D.; Mishra Meza, A.; Chakraborty, N.; Persaud, S.; Farooki, A.; Morris, M. J.
    JCO Oncology Practice (2024)

    Fulltext@MSK | Save
  • A risk analysis of alpelisib-induced hyperglycemia in patients with advanced solid tumors and breast cancer
    Journal Article

    Rodón, J.; Demanse, D.; Rugo, H. S.; Burris, H. A.; Simó, R.; Farooki, A.; Wellons, M. F.; André, F.; Hu, H.; Vuina, D.; more...
    Breast Cancer Research (2024)

    Fulltext@MSK | Save
  • Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique
    Journal Article

    Gallagher, E. J.; Moore, H.; Lacouture, M. E.; Dent, S. F.; Farooki, A.; Goncalves, M. D.; Isaacs, C.; Johnston, A.; Juric, D.; Quandt, Z.; more...
    npj Breast Cancer (2024)

    Fulltext@MSK | Save
  • Physician knowledge, practice patterns, and barriers encountered regarding guideline-concordant use of bone modifying agents for prostate cancer
    Journal Article

    Mitchell, A. P.; Persaud, S.; Palyca, P.; Salner, A.; Farooki, A.; Ostroff, J. S.; Morris, M. J.; Chimonas, S.
    Prostate (2024)

    Fulltext@MSK | Save
  • Diabetes care in the oncologic population
    Journal Article

    Presswala, L. S.; Farooki, A.; Flory, J.
    Contemporary Endocrinology (2023)

    Fulltext@MSK | Save
  • Proceedings of the 2023 Santa Fe bone symposium: Progress and controversies in the management of patients with skeletal diseases
    Review

    Lewiecki, E. M.; Bellido, T.; Bilezikian, J. P.; Brown, J. P.; Farooki, A.; Kovacs, C. S.; Lee, B.; Leslie, W. D.; McClung, M. R.; Prasarn, M. L.; more...
    Journal of Clinical Densitometry (2023)

    Fulltext@MSK | Save
  • Refractory hypercalcemia of malignancy: A problem with many potential roots
    Review

    Farooki, A.
    Frontiers in Endocrinology (2023)

    Fulltext@MSK | Save
  • Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer
    Journal Article

    Mitchell, A. P.; Mishra Meza, A.; Panageas, K. S.; Lipitz-Snyderman, A.; Farooki, A.; Morris, M. J.
    Prostate Cancer and Prostatic Diseases (2023)

    Fulltext@MSK | Save
  • Barriers to guideline-concordant use of bone modifying agents for prostate cancer
    Meeting Abstract

    Mitchell, A. P.; Persaud, S.; Chimonas, S.; Salner, A. L.; Palyca, P.; Farooki, A.; Ostroff, J. S.; Morris, M. J.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Bone remineralization of lytic lesions in newly diagnosed multiple myeloma (NDMM) patients treated with carfilzomib, lenalidomide, dexamethasone +/- daratumumab induction regimen
    Meeting Abstract

    Meseha, M.; Abusamra, M.; Farooki, A.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Shah, U.; Lu, S.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save